General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0UYIOG
ADC Name
YL-212
Synonyms
YL212; YL 212
   Click to Show/Hide
Organization
Suzhou Medilink Therapeutics Ltd.; Zai Lab Ltd.
Drug Status
Clinical candidate
Indication
In total 1 Indication(s)
Small cell lung cancer [ICD11:2C25]
Clinical candidate
Antibody Name
Undisclosed
Antigen Name
Delta-like protein 3 (DLL3)
 Antigen Info 
Payload Name
Undisclosed
Linker Name
Undisclosed
Conjugate Type
MediLinks proprietary TAMLIN platform.

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.